SAMSUNG PHARM. Co., LTD.

KSE 001360.KS

SAMSUNG PHARM. Co., LTD. Total Non-Current Liabilities for the year ending December 31, 2023: USD 2.36 M

SAMSUNG PHARM. Co., LTD. Total Non-Current Liabilities is USD 2.36 M for the year ending December 31, 2023, a 173.89% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

SAMSUNG PHARM. Co., LTD. Total Non-Current Liabilities for the year ending December 31, 2022 was USD 862.57 K, a -30.76% change year over year.
SAMSUNG PHARM. Co., LTD. Total Non-Current Liabilities for the year ending December 31, 2021 was USD 1.25 M, a -79.50% change year over year.
SAMSUNG PHARM. Co., LTD. Total Non-Current Liabilities for the year ending December 31, 2020 was USD 6.08 M, a 105.30% change year over year.
SAMSUNG PHARM. Co., LTD. Total Non-Current Liabilities for the year ending December 31, 2019 was USD 2.96 M, a -22.82% change year over year.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

KSE: 001360.KS

SAMSUNG PHARM. Co., LTD.

CEO	Mr. Won-Kyu Kim
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	35 Jeyakgongdan 2-gil
Employees	240
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care Pet Food

Description

SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also provides medicines for digestive system, medicines for liver disorder, medicines for circulation system, cold medicines, nutritional supplements, health tonics, and others, as well as vitamins and energy drinks, and functional foods. The company was founded in 1929 and is based in Hwaseong-si, South Korea.

Key trends

Past 5 years